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Background
Endometriosis, an enigmatic progressive and 
estrogen-dependent disease characterized by 
development of endometrial tissue outside 
of the uterus, causes pain and infertility on 
reproductive-aged women [1–4]. The health-
related quality of the afflicted women’s life 
is seriously decreased due to chronic pelvic 
pain and subfertility. Endometriosis was first 
described by Sampson in 1921 [5]. Although 
the exact prevalence of endometriosis is not 
well known, it was speculated as 10% of 
reproductive-aged women. However, a recent 
epidemiologic study has shown that the 
prevalence of endometriosis is 1.5% [6]. The 
prevalence of endometriosis asymptomatic 
parous women who underwent laparoscopy 
due to tubal ligation or other benign pel-
vic pathology had been reached to approxi-
mately 40% [7]. However, the prevalence of 
endometriosis in infertile women has been 
reported as 9–50% [2–4]. This severity of 
disease increases by older age due to progres-
sion of endometriosis. The advanced stages 
of endometriosis lead to the lesser fecundity.
Although the prevalence of endometriosis 
in infertile women seemed to be nearly 50%, 
all women with endometriosis are not infertile 
actually. Women diagnosed to have endome-
trioma by ultrasonography may still achieve a 
spontaneous pregnancy. Hence, endometrio-
sis is not a direct cause of infertility. Monthly 
fecundity rates drop from 25% to 2–10% in 
endometriosis [8]. Endometriosis has asso-
ciations with infertility; however, the exact 
mechanisms are yet to be defined and scientific 
evidence has not completely established.
The poor pregnancy outcomes in endome-
triosis patients were linked to reduced ovar-
ian reserve, low numbers of oocytes retrieved, 
lower oocyte and embryo quality, impair-
ment of implantation associated with reduced 
endometrial receptivity, especially in severe 
endometriosis, although contradicting reports 
suggest similar results with control cases.
Live birth rates in women with endome-
triosis are comparable to women with other 
causes in the SART reports [9]. Additionally, 
adverse pregnancy outcomes, such as preg-
nancy loss, preterm delivery, pre-eclampsia 
and intrauterine growth restriction, have 
been demonstrated to occur more frequently 
in subjects with endometriosis [10,11].
Mechanisms of infertility in 
endometriosis
The associations of infertility and endome-
triosis can be assessed by four sections:
•	 Chronic inflammation;
•	 Tuboperitoneal distortion;
•	 Hormonal changes on implantation;
•	 Decrease in ovarian reserve.
Chronic inflammation
Endometriosis is a chronic inflammatory 
state [12–14]. Normally, refluxed endome-
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trial tissue is cleared from the peritoneum by the 
immune system, and the dysregulation of this clear-
ance mechanism has been implicated in the predis-
position to implantation and growth of endometrial 
cells. Interestingly, larger tissue fragments as opposed 
to individual cells demonstrate an increased capacity 
to implant, presumably owing to the protection from 
immune clearance afforded the cells residing on the 
inner aspects of such fragments. Women with endome-
triosis have been shown to have an increased volume 
of peritoneal fluid, as well as increased peritoneal fluid 
concentrations of prostaglandins, proteases and cyto-
kines including inflammatory cytokines such as IL-1, 
IL-6, MCP-1 and TNF-α, and angiogenic cytokines, 
such as IL-8 and VEGF produced by macrophages as 
shown by our group and the others [15–21]. Peritoneal 
fluid from women with endometriosis contains more 
macrophages and activated macrophages, which was 
initially considered a consequence of low-grade inflam-
mation. More recently, it was recognized that women 
with endometriosis have higher chemotactic activity 
for macrophages in their peritoneal fluid [22] and that 
medical treatment of endometriosis can reduce this [23].
The increase in inflammatory cytokines affects 
oocyte, sperm transport and implantation process. 
Additionally, the eutopic endometrium from women 
with endometriosis was found to be more resistant 
to lysis by natural killer (NK) cells than the eutopic 
endometrium from women without disease [22]. Sub-
sequent studies identified the constitutive shedding 
of intercellular adhesion molecule-1 by endometrial 
stromal cells from women with endometriosis as the 
potential mechanism by which these cells escape NK 
cell-mediated clearance [24,25]. Impaired NK cell func-
tion may confer an immune-privileged status on the 
refluxed endometrial cells, thereby predisposing to 
disease. Menstrual effluent has a harmful effect on the 
mesothelium and may autologously induce the local 
injury that promotes the implantation of endometrial 
cells [13]. Gene expression profiling of the peritoneum 
from subjects with and without endometriosis dem-
onstrated upregulation of matrix metalloproteinase 
(MMP)-3 during the luteal phase and upregulation 
of intercellular adhesion molecule-1, TGF-β and IL-6 
during the menstrual phase [13,26]. We have shown that 
doxycycline decreased the MMP immunostaining in 
the endometrial implants and the size of the implants, 
demonstrating that MMPs are playing active role in 
the development of endometriosis [27]. These increased 
inflammatory cytokines increase phagocytotic 
responses of activated macrophages, which can give 
harm to oocyte and sperm.
Women with endometriosis have increased endo-
metrial mRNA levels of α
V
 integrin, combined α
V
β
3
 
integrins and increased peritoneal IL-1β mRNA lev-
els but decreased peritoneal MCP-1 mRNA levels in 
menstrual phase of their cycles compared with control 
subjects. They have increased endometrial mRNA 
levels of IL-1β and RANTES [18–24] and higher endo-
metrial aromatase mRNA expression in combined 
phases. Peritoneal mRNA expression of RANTES 
and VCAM-1 was reported to increase in women with 
endometriosis during the menstrual phase compared 
with luteal phase [28–30]. The evidence from increased 
expression of aromatase, cytokines and adhesion 
factors in endometrium and peritoneum suggests 
that both tissues are involved in the pathogenesis of 
endometriosis.
Minimal/mild endometriosis is associated with 
increased production of prostaglandins, metalloprotein-
ases, cytokines and chemokines leading to inflammatory 
process [12]. It is still unknown if inflammation predis-
poses to, or results from, endometriosis. These altera-
tions may have adverse effects on oocyte, sperm, embryo, 
or fallopian tube function impairs ovarian, peritoneal, 
tubal, and endometrial function, leading to defective 
folliculogenesis, fertilization and/or implantation [31].
There are recently discovered chemokines involved 
in endometriosis; ENA-78 [32] and SDF-1 [33]. These 
both cytokines are related Il-8, inducing inflamma-
tion and angiogenesis. Furthermore, this chronic 
state impairs fertilization and implantation via loss of 
implantation markers.
Tuboperitoneal anatomic distortion
Endometriosis leads adhesions around fallopian tubes, 
ovary and Douglas pouch. These adhesions can be 
found as filmy or dense which can be only diagnosed by 
laparoscopy or laparotomy. These adhesions can block 
tubal motility and/or impair the oocyte-pickup func-
tion of fimbrial end. Especially, ovary having endome-
trioma is densely adhered to fossa ovarica frequently 
which can have a detrimental effect on oocyte pickup.
Adhesions on tuboovarian junction can decrease 
tubal motility. These adhesions would be found on tubal 
end which can cause distal tubal disease. Distal tubal 
pathologies that are mainly fimosis could be diagnosed 
easily by hysterosalpingography. Progression of distal 
tubal diseases may lead to total functional loss that is 
hydrosalpenx. The villus in swollen tube would lose its 
motility which can further impair oocyte transport. 
However, the impairment of the oocyte-pickup func-
tion of fimbrial end may be due to distal tubal obstruc-
“Patients with endometriosis have reduced  
number of preovulatory follicles, follicular 
growth, dominant follicle size and follicular  
estradiol concentrations in their ovaries.”
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tion. These functional disorders that would be revealed 
by laparoscopy can be accused by endometriosis.
Hormonal changes on implantation
NK cell activity and IgG and IgA antibodies and lym-
phocytes may be increased in the endometrium of 
women with endometriosis [34]. These abnormalities may 
alter endometrial receptivity and embryo implantation. 
Autoantibodies to endometrial antigens are reported to 
be increased in some women with endometriosis [35].
The impaired luteinizing hormone (LH) production 
as the primary pathophysiology causing impaired ovu-
lation [36]. Endometriosis is associated with the lutein-
ized unruptured follicle syndrome and with a sterile 
low-grade inflammatory reaction in the peritoneal cav-
ity as judged by an increased amount of activated mac-
rophages and their secretion products [37]. In healthy 
women, the steroid hormone concentrations in perito-
neal fluid are much higher after ovulation, but this is 
not observed in women with the luteinized unruptured 
follicle syndrome.
Gonadotropin-surge attenuating factor (GnSAF) 
primarily produced by small follicles leads to a decrease 
in LH levels in endometriosis patients. GnSAF also 
decreases the ability of E2 to sensitize the pituitary to 
gonadotropin-releasing hormone for the positive feed-
back before LH surge leading suboptimal LH levels and 
impaired ovulation [38].
Increased levels of IL-6 in the preovulatory follicles 
of endometriosis patients cause aromatase activity to 
decrease through the MAPK signal pathway. This leads 
to a decrease in intrafollicular conversion of andro-
stenedione to estrone and a diminished conversion of 
androstenedione to testosterone, which is aromatized to 
E2 [39]. In the final, decreased follicular levels of E2 may 
result in decreased fertilizing capacity [39].
There is a well-known progesterone resistance in 
endometriosis [40,41]. This resistance could change 
implantation window period, which would further 
cause loss of implantation markers. The inadequacy 
of pinopodes and other markers yield to defective 
implantation process, which can lead to infertility. On 
the other hand, in patients with endometriosis there is 
well-documented increased aromatase enzyme activity 
in endometrium, which may further impair implanta-
tion. The concomitancy of progesterone resistance and 
increased aromatase activity affect the implantation 
throughout 5–6 days of implantation window period.
Decrease on ovarian reserve
Ovarian endometriosis which is endometrioma 
decreases ovarian reserve itself in especially bilat-
eral involvement [42]. The decrease on reserve would 
affect oocyte/embryo quality that could lead to 
decrease pregnancy rates in spontaneous gestation and 
IVF/ICSI cycles. Patients with endometriosis have 
reduced number of preovulatory follicles, follicular 
growth, dominant follicle size and follicular estradiol 
concentrations in their ovaries [43–45]. These patients 
have altered hormone profiles, in other words, reduced 
estrogen, androgen and progesterone and increased 
activin in their follicular fluid [46].
Decreased AMH levels after surgical excision of 
endometriomas suggest a surgery-related damage to 
ovarian reserve [47,48]. Furthermore, even unilateral 
endometrioma excisional surgery is associated with a 
significant reduction in ovarian reserve. The reduction 
is immediate and sustained over time. AMH appears 
to be a better indicator for postoperative quantification 
of the ovarian reserve [49]. However, Esinler et al. have 
demonstrated that endometriomas ≤3 cm in diam-
eter per se did not have a deleterious effect on ovarian 
reserve in ICSI cycles [50].
Endometrial polyps
Endometrial polyps are estrogen dependent like endo-
metriosis and estrogen receptors and aromataselev-
els are shown to be increased in polyps [51] and polyp 
removal increasespregnancy rate in women with unex-
plained infertility [52]. A recent meta-analysis showed 
that endometrial polyps are increased in woment 
with endometriosis (relative risk: 2.8 [95% CI: 
2.48–3.18]) [53].
Conclusion
In conclusion, endometriosis is a disease where infer-
tility may be seen. The reasons for infertility may be 
due to cytokine release due to inflammatory process 
of endometriosis, tuboperitoneal anatomic distortion, 
decrease in implantations, decreased ovarian reserve 
and endometrial polyps. The gynecologist must 
inform the patient about these mechanisms, and refer 
Executive summary
•	 The advanced stages of endometriosis lead to the lesser fecundity.
•	 Endometriosis is not a direct cause of infertility.
•	 Monthly fecundity rates drop from 25% to 2–10% in endometriosis.
•	 Mechanisms of infertility in endometriosis involve chronic inflammation, tuboperitoneal distortion, hormonal 
changes on implantation, decrease in ovarian reserve and endometrial polyps.
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the patient to an infertility specialist to discuss her 
future fertility potential.
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